Our study suggests an effective treatment regimen of 250 μg/ml of anti-EGFR-MPB nanocomposite combined with 1.0 W/cm2 laser irradiation for 7 min for treating triple-negative breast cancer. This evidence concerns the gene EGFR and triple-negative breast carcinoma.